A New Fluoroquinolone Derivative Exhibits Inhibitory Activity against Human Immunodeficiency Virus Type 1 Replication

Publisher： Karger

E-ISSN： 1421-9794|45|1|48-55

ISSN： 0009-3157

Source： Chemotherapy, Vol.45, Iss.1, 1999-01, pp. : 48-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Activity of Trovafloxacin (CP 99,219), a New Fluoroquinolone against Hospital Isolates

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-01 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors

By De Feo Christopher J.   Weiss Carol D.  

Viruses, Vol. 4, Iss. 12, 2012-12 ,pp. : 3859-3911

MDPI

Access to resources Recommend Favorite

First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection

By Fowler Lauren   Conceicao Viviane   Perera Suneth S.   Gupta Priyanka   Chew Choo Beng   Dyer Wayne B.   Saksena Nitin K.  

Medical Sciences, Vol. 4, Iss. 2, 2016-05 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Impact of Human Immunodeficiency Virus Type-1 Sequence Diversity on Antiretroviral Therapy Outcomes

By Langs-Barlow Allison   Paintsil Elijah  

Viruses, Vol. 6, Iss. 10, 2014-10 ,pp. : 3855-3872

MDPI

Access to resources Recommend Favorite

Effect of Probiotic Bacteria on Microbial Host Defense, Growth, and Immune Function in Human Immunodeficiency Virus Type-1 Infection

By Cunningham-Rundles Susanna   Ahrné Siv   Johann-Liang Rosemary   Abuav Rachel   Dunn-Navarra Ann-Margaret   Grassey Claudia   Bengmark Stig   Cervia Joseph S.  

Nutrients, Vol. 3, Iss. 12, 2011-12 ,pp. : 1042-1070

MDPI

Access to resources Recommend Favorite